Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00547677 · ClinicalTrials.gov registry record · Phase 1
Stereotactic Radiosurgery for Patients With Hepatic Metastases.
A Phase 1 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT00547677 is a Phase 1 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 27 participants.
The verdict
NCT00547677, a Phase 1 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase I trial is studying the side effects and best dose of stereotactic radiosurgery in treating patients with liver metastases.
Interventions
- RADIATION stereotactic radiosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2004-07 |
| Est. Completion | 2008-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00547677
The ClinicalTrials.gov registry entry for NCT00547677 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which stereotactic radiosurgery is the first listed.
NCT00547677 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00547677 about?
NCT00547677 is a clinical study titled "Stereotactic Radiosurgery for Patients With Hepatic Metastases.". RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase I trial is studying the side effects and best dose of stereotactic radiosurgery in treating patients with liver metastases.
What is the current status of trial NCT00547677?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2004-07. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00547677?
The interventions under investigation include: stereotactic radiosurgery (RADIATION).
Who is sponsoring clinical trial NCT00547677?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.